User talk:FiveOhThreeA
Editor talk page·2 messages
Welcome, and thank you for Beyond-use date
Welcome. Your work on Beyond-use date was a useful addition — it was one of the thinner pages in its topic area.
One convention to note for next time: numeric claims need an inline citation each, not one citation at the end of the paragraph, because the paragraph usually ends up split later and the citation then attaches to the wrong sentence. See Project:Sourcing guidelines. — UnitAuditUwe (talk) 08:03, 25 August 2025 (UTC)
Source for the incidence figure in Nantong Guangyuan Chemical
In Nantong Guangyuan Chemical you added an incidence figure without its comparator rate. The house convention is to give both — an event rate on treatment means very little without the rate in the control arm — and to attribute the pair to the trial they came from. Would you be able to add the placebo rate and the citation? — EpitalonEoin (talk) 01:43, 12 January 2026 (UTC)
Fair — the tags are reasonable and I will work through them. Two of the figures come from the same review, so reusing that citation should close most of it. — FiveOhThreeA (talk) 09:55, 12 January 2026 (UTC)